We included 852 patients in a prospectively recruiting multicenter matched case-control study in Germany to assess vaccine effectiveness (VE) in preventing COVID-19-associated hospitalization during the Delta-variant dominance. The two-dose VE was 89 % (95 % CI 84-93 %) overall, 79 % in patients with more than two comorbidities and 77 % in adults aged 60-75 years. A third dose increased the VE to more than 93 % in all patient-subgroups.
Keywords: COVID-19; Case-control study; Delta; Hospitalization; SARS-CoV-2; Vaccine effectiveness.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.